Skip to content
Investing

Serabi Gold: Investor Profile of the Brazilian Gold Miner Behind Palito and Coringa

Serabi Gold mines gold at Palito and Coringa in Brazil's Tapajós region. Its assets, first-half 2026 profit, cash and share count, the permit risks behind its guidance cut and the dates to watch.

The entrance portal of Serabi Gold's Palito underground mine, with a Mina do Palito sign over the tunnel, a gravel access road and forest-covered hillside around it.
Photo: Serabi Gold

Serabi Gold is a small gold producer working two underground mines in the Tapajós region of Pará state, northern Brazil. It is profitable and debt-free, but its plan to grow output hinges on permits for its Coringa mine. This profile covers its assets, latest numbers, share structure, risks and the dates ahead.

What Serabi does and where

Serabi Gold plc is headquartered in the United Kingdom with a secondary office in Toronto. Its shares trade on London's AIM market as SRB, on the Toronto Stock Exchange as SBI and on the US OTCQX market as SRBIF. It reports in US dollars.

The company describes itself as a gold exploration, development and production company focused on the Tapajós. It has historically produced 30,000 to 40,000 ounces a year from the Palito Complex and is adding output from Coringa. It also reports a copper-gold porphyry discovery on its wider exploration licence.

According to the company's share structure page, last updated on 2 June 2026, it has 76,307,760 ordinary shares in issue and 2,200,163 conditional share awards, giving 78,507,923 shares on a fully diluted basis. Its largest shareholder is Classe Roca Magma FIP with 24.99%, followed by Ruffer with 3.8%, while directors hold 0.7%.

Serabi Gold: share price, chart and news

Serabi Gold's gold processing plant at dusk, its lit steel tower and conveyor gantry standing above the cleared ground.
Serabi Gold's gold processing plant at dusk, its lit steel tower and conveyor gantry standing above the cleared ground. Photo: Serabi Gold

The mines and the resource base

Palito Complex. Palito is the company's established mine and hosts the only processing plant. Ore comes from several veins, including Barrichello, G3, Ipe and Piquet. A fourth ball mill, now in final commissioning, raises plant capacity from 650 tonnes a day to more than 900, which the company says lifts annual throughput to 330,000 tonnes in 2027. Palito's grades have been weak in 2026: the year-to-date milled grade to September was 4.90 g/t, and the company expects improvement in the fourth quarter as more ore comes from the G3 vein.

Coringa. Coringa is the growth asset. It produced 23,089 ounces in the first nine months of 2026, more than two thirds of group output, at a year-to-date milled grade of 7.74 g/t. Mining is under way in four zones: Serra, Serra South, Meio and Galena. The mine is moving from manual selective mining to mechanised sublevel open stoping, a change the company expects to complete in the fourth quarter of 2026.

Coringa has no plant of its own. Its ore is trucked to Palito under a GUIA trial mining licence that caps transport at 100,000 tonnes a year and expires on 29 January 2027. The full operating licence still needs approvals from FUNAI, the federal agency for Indigenous peoples, and INCRA, the land agency.

São Chico. A third, smaller mine has been on care and maintenance since 2023. Serabi is assessing a restart, which would depend on completing that assessment and on renewing the mine's GUIA licence.

Resources and exploration. After its 2025 drilling, Serabi reported consolidated measured and indicated resources of 730,800 ounces of gold in 2,485,800 tonnes at 9.1 g/t, plus inferred resources of 653,300 ounces in 2,506,700 tonnes at 8.1 g/t. Its stated goal is a group mineral inventory of more than 1.5 million ounces.

The 2026 brownfield programme totals 32,000 metres at Palito and Coringa; 20,831 metres had been drilled by mid-year. Results published on 21 September included 1.38 metres at 11.85 g/t at Serra South and, on the mine laboratory's internal assay, 1.70 metres at 16.13 g/t at Coringa's Meio zone. Updated resource estimates for both mines are expected in the first quarter of 2027.

Latest reported numbers

Key figures

  • $30.1m profit after tax in the first half of 2026
  • $63.2m cash at 30 September 2026, no debt
  • 34,057 oz gold produced in the first nine months
MeasureH1 2026H1 2025
Revenue$100.1m$62.5m
EBITDA$44.4m$26.3m
Profit after tax$30.1m$18.9m
Earnings per share39.71c24.99c
Average gold price received$4,687/oz$3,093/oz
Cash cost$2,010/oz$1,379/oz
All-in sustaining cost$2,682/oz$1,792/oz

Net assets were $206.5 million at 30 June. The company repaid its Banco Santander working capital facility in January 2026, paid a maiden dividend of $5.1 million in July and has been debt-free since. A tax incentive at Palito, keeping the nominal corporate tax rate there at about 15.25% instead of 34%, was renewed until 2035.

On 21 October Serabi cut its 2026 production guidance from more than 53,000 ounces to a level similar to 2025's 44,169 ounces, blaming the permitting delays at Coringa.

Main risks

Risks investors should weigh

  • Permits. Growth depends on Brazilian approvals, from the GUIA extension to FUNAI, INCRA and the operating licence, whose timing Serabi does not control.
  • Grades. Palito's grades fell well below budget in 2026, and the guidance cut shows how quickly output can change.
  • Rising costs. All-in sustaining costs climbed by about half in a year, partly from the Coringa ramp-up and one-off overheads.
  • Concentration. All production is in one region of one country and runs through one processing plant.
  • Safety and people. Two employees died in underground accidents in January 2026, at Coringa on 25 January and at Palito on 30 January. Its finance chief, Colm Howlin, stepped down in August; Nick Box is interim CFO while a successor is sought.

Gold price moves feed directly into revenue and profit, so a fall in the metal would squeeze margins that are already narrowing as costs rise.

What to watch next

WhenWhat
Late November 2026Third-quarter financial results and updated 2026 guidance
Q4 2026Completion of the move to mechanised stoping at Coringa
By 29 January 2027ANM decision on extending the Coringa GUIA or its tonnage limit
Q1 2027Updated mineral resource estimates for Palito and Coringa
2027Lower capital spending, as guided, and use of the expanded Palito plant

Serabi has the cash and the plant capacity to grow. Whether it does so in 2027 depends mainly on the permit decisions due over the coming months.

Sources

Related stories

Markets

Serabi Gold Cuts Its 2026 Output Guidance as Coringa Permits Stall

Serabi Gold now expects 2026 output near 2025's 44,169 ounces, not over 53,000, as Coringa permits stall. Third-quarter production fell 9% to 11,008 ounces; cash stood at $63.2m…

Investing

Ero Copper: Investor Profile of the Brazil-Focused Copper and Gold Producer

Ero Copper mines copper at Caraíba and Tucumã and gold at Xavantina, all in Brazil. Its assets, record Q3 2026 numbers, debt, share count, main risks and the milestones to watch.

Investing

Hot Chili: Investor Profile of the Costa Fuego Copper Developer and Its La Verde Discovery

Hot Chili is developing the Costa Fuego copper-gold project in Chile's coastal Atacama and drilling a fast-growing discovery at La Verde. Its assets, latest numbers, cash, risks…

Investing

Alkane Resources: Investor Profile of the Gold and Antimony Miner in Australia and Sweden

Alkane Resources mines gold at Tomingley and Björkdal and gold-antimony at Costerfield. Its assets, record FY26 profit, cash, share count, the main risks and the milestones to…

Investing

Aya Gold & Silver Corrects Q3 Cash Costs to $14.28 an Ounce After Silver Double Count

Aya Gold & Silver refiled its Q3 MD&A after silver in transit was deducted twice. Zgounder ounces sold rise to 1,392,478 and cash costs fall to $14.28 from $15.51. Revenue and…

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Berkshire Reveals $689m Bending Spoons Stake, Doubles Lennar and Trims Bank of America Again

Berkshire Hathaway's third-quarter 13F shows a new Bending Spoons stake worth $689m, a doubled Lennar holding and 27.5 million more Bank of America shares sold, while Apple stayed…